Resverlogix Corp (RVXCF)
0.0348
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Resverlogix Total Liabilities (Quarterly): 80.54M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 80.54M |
December 31, 2023 | 80.99M |
September 30, 2023 | 79.36M |
June 30, 2023 | 75.12M |
December 31, 2022 | 67.40M |
September 30, 2022 | 70.50M |
June 30, 2022 | 70.05M |
March 31, 2022 | 70.92M |
December 31, 2021 | 69.85M |
September 30, 2021 | 54.81M |
June 30, 2021 | 52.75M |
March 31, 2021 | 49.82M |
October 31, 2020 | 63.32M |
July 31, 2020 | 76.59M |
April 30, 2020 | 75.49M |
January 31, 2020 | 86.96M |
October 31, 2019 | 95.46M |
July 31, 2019 | 214.17M |
April 30, 2019 | 224.01M |
January 31, 2019 | 170.86M |
October 31, 2018 | 168.41M |
July 31, 2018 | 147.24M |
April 30, 2018 | 91.96M |
January 31, 2018 | 87.04M |
October 31, 2017 | 128.61M |
Date | Value |
---|---|
July 31, 2017 | 120.80M |
April 30, 2017 | 112.44M |
January 31, 2017 | 103.99M |
October 31, 2016 | 98.98M |
July 31, 2016 | 94.66M |
April 30, 2016 | 96.53M |
January 31, 2016 | 88.57M |
October 31, 2015 | 88.39M |
July 31, 2015 | 89.88M |
April 30, 2015 | 94.88M |
January 31, 2015 | 76.30M |
October 31, 2014 | 80.06M |
July 31, 2014 | 57.67M |
April 30, 2014 | 66.24M |
January 31, 2014 | 67.56M |
October 31, 2013 | 84.35M |
July 31, 2013 | 89.11M |
April 30, 2013 | 50.00M |
January 31, 2013 | 34.23M |
October 31, 2012 | 28.57M |
July 31, 2012 | 10.62M |
April 30, 2012 | 9.63M |
January 31, 2012 | 8.955M |
October 31, 2011 | 9.20M |
July 31, 2011 | 10.42M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
49.82M
Minimum
Mar 2021
214.17M
Maximum
Jul 2019
79.67M
Average
73.02M
Median
Total Liabilities (Quarterly) Benchmarks
CeCors Inc | -- |
Venus Concept Inc | 106.99M |
Acasti Pharma Inc | 11.50M |
Aurinia Pharmaceuticals Inc | 170.11M |
Edesa Biotech Inc | 2.151M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 7.446M |
Shareholders Equity (Quarterly) | -73.09M |